Ascensia Announces Strategic Partnership with Sava for Innovative Microsensor Technology

Ascensia Announces Strategic Partnership with Sava for Innovative Microsensor Technology

BASEL, Switzerland--(BUSINESS WIRE)--Oct 9, 2026-

Ascensia Leads $36M In Sava And Takes Its Europe Rights

Sava raised $36M led by Ascensia Diabetes Care, which also won exclusive European distribution. No regulator has approved the London company's glucose sensor, and it has published no accuracy number.

London’s Sava raises €32.08 million and partners with Ascensia to bring its glucose microsensor to Europe

Sava Technologies, a London-based HealthTech company developing a wearable biosensor platform that detects molecules just beneath the skin, today announced a €32.08 million ($36 million) Series B round to fund manufacturing scale-up and commercial readiness. The round was led by Ascensia, with participation from institutional investors Balderton Capital, Norrsken VC, Simplyhealth Ventures, JamJar Investments, Pentland […]

Ascensia leads $36M Series B in Sava to replace fingerstick glucose testing

London medtech Sava secures $36m Series B led by CONTOUR-maker Ascensia Diabetes Care to take its multi-analyte glucose microsensors to clinical trials in Europe